Ocugen Inc (NASDAQ: OCGN) kicked off on Friday, up 2.00% from the previous trading day, before settling in for the closing price of $1.0. Over the past 52 weeks, OCGN has traded in a range of $0.51-$1.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.82%. While this was happening, its average annual earnings per share was recorded -10.00%. With a float of $286.77 million, this company’s outstanding shares have now reached $292.03 million.
Let’s determine the extent of company efficiency that accounts for 95 employees. In terms of profitability, gross margin is 100.0%, operating margin of -1261.43%, and the pretax margin is -1271.12%.
Ocugen Inc (OCGN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 26.32%. The most recent insider transaction that took place on Jul 09 ’25, was worth 122,887. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 146,705 for $1.17, making the entire transaction worth $171,029.
Ocugen Inc (OCGN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -10.00% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Take a look at Ocugen Inc’s (OCGN) current performance indicators. Last quarter, stock had a quick ratio of 2.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 65.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Looking closely at Ocugen Inc (NASDAQ: OCGN), its last 5-days average volume was 3.55 million, which is a drop from its year-to-date volume of 4.82 million. As of the previous 9 days, the stock’s Stochastic %D was 33.98%.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 65.16%, which indicates a significant increase from 40.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0718 in the past 14 days, which was higher than the 0.0704 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9516, while its 200-day Moving Average is $0.8299. However, in the short run, Ocugen Inc’s stock first resistance to watch stands at $1.0500. Second resistance stands at $1.0800. The third major resistance level sits at $1.1200. If the price goes on to break the first support level at $0.9800, it is likely to go to the next support level at $0.9400. Now, if the price goes above the second support level, the third support stands at $0.9100.
Ocugen Inc (NASDAQ: OCGN) Key Stats
The company with the Market Capitalisation of 297.87 million has total of 292,031K Shares Outstanding. Its annual sales at the moment are 4,060 K in contrast with the sum of -54,050 K annual income. Company’s last quarter sales were recorded 1,480 K and last quarter income was -15,350 K.
